Patent · US Active

Aryl sulfonamide compounds for treating obesity

US7718650B2 · kind B2 · utility

0Cited by

7References

13Claims

0Family size

Assignee

Biovitrum AB · SE

Inventors

Ulf Bremberg · Upplands Väsby, SE
Patrizia Caldirola · Uppsala, SE
Annika Jensen · Uppsala, SE
Gary Johansson · Hockessin, US
Lori Sutin · Knivsta, SE
Andrew Mott · Knivsta, SE
Jan Tejbrant · Stuvsta-Snättringe, SE

Key dates

Filing date	Dec 19, 2007
Grant date	May 18, 2010
Priority date	—
Expiry date	Dec 19, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.